Abstract
A modular systems biology approach may be useful to gain a better understanding of complex cellular processes, such as cell cycle and ageing. We show in fact in this review that this approach has been successfully applied to the identification of the long sought molecular mechanism able to set the critical cell size required to enter S phase in budding yeast. It involves two sequential thresholds set by the cyclin dependent kinase inhibitors Far1 and Sic1, that cooperate in carbon source modulation of the critical cell size required to enter S phase, a hallmark of response of the cell cycle to changing growth conditions. After this initial validation, the approach is tested to extract from available literature data a blueprint of ageing in budding yeast. The blueprint newly proposes that the process of ageing is initiated at the level of the yeast cell wall, due to the increase in size of ageing mother cells. This event would result in a mechanical stress of the cell wall that generates a signaling response able to activate two interconnected major cellular responses involved in ageing: stress metabolism and chromatin remodelling. The ensuing new approach to ageing studies is described in comparison with current theories of cell ageing.
Keywords: cell cycle, ageing, systems biology, saccharomyces cerevisiae
Current Genomics
Title: Probing Control Mechanisms of Cell Cycle and Ageing in Budding Yeast
Volume: 5 Issue: 8
Author(s): L. Alberghina, M. Vai and M. Vanoni
Affiliation:
Keywords: cell cycle, ageing, systems biology, saccharomyces cerevisiae
Abstract: A modular systems biology approach may be useful to gain a better understanding of complex cellular processes, such as cell cycle and ageing. We show in fact in this review that this approach has been successfully applied to the identification of the long sought molecular mechanism able to set the critical cell size required to enter S phase in budding yeast. It involves two sequential thresholds set by the cyclin dependent kinase inhibitors Far1 and Sic1, that cooperate in carbon source modulation of the critical cell size required to enter S phase, a hallmark of response of the cell cycle to changing growth conditions. After this initial validation, the approach is tested to extract from available literature data a blueprint of ageing in budding yeast. The blueprint newly proposes that the process of ageing is initiated at the level of the yeast cell wall, due to the increase in size of ageing mother cells. This event would result in a mechanical stress of the cell wall that generates a signaling response able to activate two interconnected major cellular responses involved in ageing: stress metabolism and chromatin remodelling. The ensuing new approach to ageing studies is described in comparison with current theories of cell ageing.
Export Options
About this article
Cite this article as:
Alberghina L., Vai M. and Vanoni M., Probing Control Mechanisms of Cell Cycle and Ageing in Budding Yeast, Current Genomics 2004; 5 (8) . https://dx.doi.org/10.2174/1389202043348652
DOI https://dx.doi.org/10.2174/1389202043348652 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of Endoplasmic Reticulum Stress: An Opportunity to Prevent Neurodegeneration?
CNS & Neurological Disorders - Drug Targets The Vpu Protein and its Role in HIV-1 Pathogenesis
Current Genomics The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design Alcoholism and its Effects on the Central Nervous System
Current Neurovascular Research Metabolic Profile of Flunitrazepam: Clinical and Forensic Toxicological Aspects
Drug Metabolism Letters Apoptosis Following Photodynamic Tumor Therapy: Induction, Mechanisms and Detection
Current Pharmaceutical Design On the Genetics of Innate Immunity in Crohns Disease
Current Genomics The Two Faces of Protein Palmitoylation in Islet β-Cell Function: Potential Implications in the Pathophysiology of Islet Metabolic Dysregulation and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Recent Developments in Anti-dotes Against Anthrax
Recent Patents on Anti-Infective Drug Discovery Small RNAs Play Big Roles: MicroRNAs in Diabetic Wound Healing
Current Molecular Medicine Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation
Current Medicinal Chemistry Molecular Damage in Glaucoma: from Anterior to Posterior Eye Segment. The MicroRNA Role
MicroRNA Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity
Current Pharmaceutical Biotechnology Disintegrins
Current Drug Targets - Cardiovascular & Hematological Disorders Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection
Current Cancer Drug Targets Inhibition of RNA Virus Infections with Peptide-Conjugated Morpholino Oligomers
Current Pharmaceutical Design Stem Cells in Adult Human Ovaries: From Female Fertility to Ovarian Cancer
Current Pharmaceutical Design Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine